As PGx Matures, US Medical Schools Struggle to Keep Students Informed | GenomeWeb

Drug makers and pharmacogenomics researchers anxious that physicians entering practice today will be ill-equipped to embrace personalized medicine may have reason to worry.

Some medical schools, aware that pharmacogenomics is caught in a limbo between its potential real-world application and hype, are encouraging their students to probe the new discipline delicately. But instead of committing to traditional textbooks and core curricula, most medical schools instead are relying on the age-old tool of learning by osmosis — that is, learning by observing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.